ASGR2

asialoglycoprotein receptor 2, the group of C-type lectin domain containing

Basic information

Region (hg38): 17:7101322-7115700

Links

ENSG00000161944NCBI:433OMIM:108361HGNC:743Uniprot:P07307AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ASGR2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASGR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
18
clinvar
2
clinvar
20
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 18 2 2

Variants in ASGR2

This is a list of pathogenic ClinVar variants found in the ASGR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-7101587-G-A Benign (Apr 24, 2018)786837
17-7101590-G-A Benign (Dec 31, 2019)721041
17-7101663-G-A not specified Uncertain significance (Jun 05, 2023)2516959
17-7101685-C-G not specified Uncertain significance (Mar 28, 2024)3317987
17-7101700-C-T not specified Uncertain significance (Jan 29, 2024)3130300
17-7101706-C-T not specified Uncertain significance (Aug 10, 2021)2342640
17-7101729-A-C not specified Uncertain significance (Feb 27, 2023)2490044
17-7102136-C-G not specified Uncertain significance (Jul 26, 2022)2303181
17-7102145-C-T not specified Uncertain significance (Feb 27, 2023)2469562
17-7102165-T-C not specified Uncertain significance (Jan 31, 2024)3130298
17-7102177-G-A not specified Uncertain significance (May 11, 2022)2378555
17-7107119-C-T not specified Uncertain significance (Apr 04, 2023)2532372
17-7107142-C-T not specified Uncertain significance (Jan 30, 2024)3130297
17-7107264-C-G not specified Likely benign (Apr 09, 2024)3317995
17-7107270-G-A not specified Uncertain significance (Sep 25, 2023)3130296
17-7107279-C-T not specified Uncertain significance (Jan 04, 2024)3130295
17-7107899-C-T not specified Uncertain significance (May 23, 2023)2511994
17-7108477-C-G not specified Uncertain significance (Nov 09, 2023)3130294
17-7108488-G-A not specified Likely benign (Jan 31, 2024)3130293
17-7108500-G-A not specified Uncertain significance (Jan 04, 2022)2269721
17-7108534-G-A not specified Uncertain significance (Nov 17, 2022)2267645
17-7108761-G-T not specified Uncertain significance (Sep 14, 2023)2624391
17-7108822-A-G not specified Uncertain significance (Aug 04, 2023)2615982
17-7114132-T-C not specified Likely benign (Jun 03, 2022)2400247

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ASGR2protein_codingprotein_codingENST00000380952 814379
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
9.81e-100.09051257140341257480.000135
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2851761870.9410.00001092065
Missense in Polyphen5965.1920.90502810
Synonymous0.2287577.50.9670.00000500571
Loss of Function0.06011414.20.9836.09e-7152

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003230.000309
Ashkenazi Jewish0.00009920.0000992
East Asian0.0002170.000217
Finnish0.000.00
European (Non-Finnish)0.0001500.000149
Middle Eastern0.0002170.000217
South Asian0.0001710.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mediates the endocytosis of plasma glycoproteins to which the terminal sialic acid residue on their complex carbohydrate moieties has been removed. The receptor recognizes terminal galactose and N-acetylgalactosamine units. After ligand binding to the receptor, the resulting complex is internalized and transported to a sorting organelle, where receptor and ligand are disassociated. The receptor then returns to the cell membrane surface.;
Pathway
Thyroid hormone synthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;Asparagine N-linked glycosylation (Consensus)

Intolerance Scores

loftool
0.835
rvis_EVS
-0.36
rvis_percentile_EVS
29.16

Haploinsufficiency Scores

pHI
0.185
hipred
N
hipred_score
0.139
ghis
0.545

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.572

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Asgr2
Phenotype
homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;

Gene ontology

Biological process
receptor-mediated endocytosis;cell surface receptor signaling pathway;viral process;protein N-linked glycosylation via asparagine;bone mineralization;regulation of protein stability;lipid homeostasis
Cellular component
plasma membrane;integral component of membrane;endoplasmic reticulum quality control compartment;perinuclear region of cytoplasm
Molecular function
asialoglycoprotein receptor activity;protein binding;carbohydrate binding